Judge Approves $600 Million Botox Settlement

A federal investigation into Allergan's misleading marketing of its wrinkle-smoothing Botox medication is over after a judge in Georgia on Tuesday approved the pharmaceutical firm's decision to pay $600 million and plead guilty to misbranding the product.

Virtual Radiologic Deal: More Small-Cap Buyouts Ahead?

Virtual Radiologic provides remote diagnostic image interpretation, giving doctors anywhere fast answers about patients' medical scans. But vRad's growth hasn't been rapid enough to please the fickle market, which made it an attractive target for a private-equity buyout from Providence Equity Partners.